Results for ic95(1) translation from French to English

(ic95 %)
(95% ci)

rr (ic95 %)
< 0.0001 / < 0.0001

différence [ic95 ]
difference [95% ci]

ic95 % 45 min, 1 h 56 min
ci95% 45 min, 1 h 56

placebo (ic95%), p
tropos

ic95% 45 min, 1 h 56 min etude ii:
study ii:

1,032(semaines)[ ic95%:
1.032 [ 95% ci:

ic95% 0,93%; 7,97%
4.5% (0 h 35 min) ci95% 0.93%, 7.97%

(8,3%) ic95% 45 min, 1 h 56 min etude ii:
(8.3%) ci95% 45 min, 1 h 56 min study ii:

orr (réponses partielles uniquement) (ic95 %)
orr (partial responses only) (95% ci)

7%, ic95% -2%; 17%).
at the end of the maintenance treatment an improvement of at least 30% was seen in 60% of the subjects receiving rotigotine, 67% of the subjects receiving pramipexole and 35% of the subjects receiving placebo (difference rotigotine versus placebo 25%; ci95% 13%; 36%, difference pramipexole versus placebo 32% ci95% 21%; 43%, difference pramipexole versus rotigotine 7%; ci95% -2%; 17%). the mean reduction in the “ off” time was 2.5 hours in the rotigotine arm, 2.8 hours in the pramipexole arm and 0.9 hours in the placebo arm.

risque relatif vs warfarine (ic95 %)
hazard ratio over warfarin (95 % ci)

risque relatif vs. warfarine (ic95 %)
hazard ratio vs. warfarin (95 % ci)

réduction par rapport au placebo (ic95%)
change relative to placebo (ci95%)

n/n % ic95 % n/n % ic95
n/n % 95% ci n/n % 95% ci

délai médian jusqu’ à événement (jours) (ic95%)
median time to event (days)

risque relatif : 1,032 [ic95% :
hazard ratio: 1.032

réduction du risque relatif vs. placebo (ic95%), p
relative risk reduction vs. placebo (95%ci), p value

52,8­65,9) dans le bras at versus 46,5% (ic95%:
52.8 -65.9) in at arm versus 46.5% (95% ci:

5,4% [ ic95%: -1,1; 12,0 ] différence entre les traitements:
5.4% [ 95% ci: -1.1; 12.0 ] treatment difference: